Buchumschlag

PKBOIN‐12: A Bayesian Optimal Interval Phase I/II Design Incorporating Pharmacokinetics Outcomes to Find the Optimal Biological Dose

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Hao Sun, Jieqi Tu
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Pharmaceutical Statistics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

A Phase I Dose‐Finding Design Incorporating Intra‐Patient Dose Escalation
von: Beibei Guo, et al.
Veröffentlicht: (2024)

A Dose‐Finding Design for Drug Combinations Using a Bayesian 4 Parameter Logistic Model With Penalised D‐Optimality
von: Maxine Ajimi, et al.
Veröffentlicht: (2026)

A Bayesian Dynamic Model‐Based Adaptive Design for Oncology Dose Optimization in Phase I/II Clinical Trials
von: Yingjie Qiu, et al.
Veröffentlicht: (2024)

BOIN ‐ MEM : A Two‐Stage Design for Dose Optimization With Information Borrowing Across Dose Levels and Stages in Oncology Phase I/ II Trials
von: Ryo Kitabayashi, et al.
Veröffentlicht: (2025)

A Likelihood Perspective on Dose‐Finding Study Designs in Oncology
von: Zhiwei Zhang
Veröffentlicht: (2024)

CUSUMIN Combination: A Cumulative Sum Interval Design for Phase I Cancer Drug‐Combination Trials
von: Tomoyoshi Hatayama, et al.
Veröffentlicht: (2025)

A Model‐Based Trial Design With a Randomization Scheme Considering Pharmacokinetics Exposure for Dose Optimization in Oncology
von: Jun Zhang, et al.
Veröffentlicht: (2024)

Reparametrized Firth's Logistic Regressions for Dose‐Finding Study With the Biased‐Coin Design
von: Hyungwoo Kim, et al.
Veröffentlicht: (2024)

Informing the Borrowing Process for Dose‐Finding Trials by Estimating the Similarity Between Population‐Specific Dose‐Toxicity Curves
von: Dario Zocholl, et al.
Veröffentlicht: (2025)

A Personalized Dose‐Finding Algorithm Based on Adaptive Gaussian Process Regression
von: Yeonhee Park, et al.
Veröffentlicht: (2024)

Finding the Optimal Number of Splits and Repetitions in Double Cross‐Fitting Targeted Maximum Likelihood Estimators
von: Mohammad Ehsanul Karim, et al.
Veröffentlicht: (2025)

Utility‐Based Dose Optimization Approaches for Multiple‐Dose Randomized Trial Designs Accounting for Multiple Endpoints
von: Gina D'Angelo, et al.
Veröffentlicht: (2025)

A Tobit Partly Linear Mixed and Mixture Cure Model for the Joint Analysis of Interval‐Bounded Longitudinal Measurements and Survival Times With Cure Proportion
von: Zhanfeng Wang, et al.
Veröffentlicht: (2026)

Great Wall: A Generalized Dose Optimization Design for Drug Combination Trials Maximizing Survival Benefit
von: Yan Han, et al.
Veröffentlicht: (2025)

A Bayesian Hybrid Design With Borrowing From Historical Study
von: Zhaohua Lu, et al.
Veröffentlicht: (2024)

Bayesian Hierarchical Models for Subgroup Analysis
von: Yun Wang, et al.
Veröffentlicht: (2024)

Bayesian Response Adaptive Randomization for Randomized Clinical Trials With Continuous Outcomes: The Role of Covariate Adjustment
von: Vahan Aslanyan, et al.
Veröffentlicht: (2024)

New, Shorter Small‐Sample Intervals for Vaccine Efficacy
von: Mauro Gasparini, et al.
Veröffentlicht: (2026)

Evaluating Safety Rules in Ongoing Dose‐Escalation Trials Using BOIN : A Comparative Analysis of Criteria and Their Impact on Dose‐Level Safety Assessments
von: Stefan Englert, et al.
Veröffentlicht: (2026)

Designing and Evaluating Bayesian Advanced Adaptive Randomised Clinical Trials: A Practical Guide
von: Anders Granholm, et al.
Veröffentlicht: (2025)

Optimal Cut‐Point Selection Methods Under Binary Classification When Subclasses Are Involved
von: Jia Wang, et al.
Veröffentlicht: (2024)

To Dilute or Not to Dilute: Nominal Titer Dosing for Genetic Medicines
von: Paul Faya, et al.
Veröffentlicht: (2024)

Prediction Intervals for Overdispersed Binomial Endpoints and Their Application to Toxicological Historical Control Data
von: Max Menssen, et al.
Veröffentlicht: (2025)

Confidence Intervals for Validation of Analytical Procedures Under ICH Q2 ( R2 )
von: Paul Faya, et al.
Veröffentlicht: (2025)

Methodological Approaches for the Estimation of Confidence Intervals on Partial Youden Index Under Verification Bias
von: Sihan Jia, et al.
Veröffentlicht: (2026)

Adaptive Constrained Weighted Estimation for Incorporating Multiple External Information Sources
von: Keita Takahashi, et al.
Veröffentlicht: (2025)

Confidence Intervals for the Risk Difference Between Secondary and Primary Infection Based on the Method of Variance Estimates Recovery
von: Chao Chen, et al.
Veröffentlicht: (2024)

A Flexible Seamless Phase 2/3 Design With Biomarker‐Driven Subgroup Enrichment and Sample Size Re‐Estimation
von: Zizhong Tian, et al.
Veröffentlicht: (2025)

Comparing various Bayesian random‐effects models for pooling randomized controlled trials with rare events
von: Minghong Yao, et al.
Veröffentlicht: (2024)

Assessment of Responder Analyses for Patient‐Reported Outcomes With Varying Variability Between Intervention Groups: Maximum Responder Threshold and Effect
von: Joseph C. Cappelleri, et al.
Veröffentlicht: (2026)

Control of Unconditional Type I Error in Clinical Trials With External Control Borrowing—A Two‐Stage Adaptive Design Perspective
von: Ping Gao, et al.
Veröffentlicht: (2025)

An Adaptive Three‐Arm Comparative Clinical Endpoint Bioequivalence Study Design With Unblinded Sample Size Re‐Estimation and Optimized Allocation Ratio
von: David Hinds, et al.
Veröffentlicht: (2024)

Taylor Series Approximation for Accurate Generalized Confidence Intervals of Ratios of Log‐Normal Standard Deviations for Meta‐Analysis Using Means and Standard Deviations in Time Scale
von: Pei‐Fu Chen, et al.
Veröffentlicht: (2025)

Bayesian Methods for Quality Tolerance Limit (QTL) Monitoring
von: J. C. Poythress, et al.
Veröffentlicht: (2024)

Prospectively Specified Adaptive Bayesian Borrowing: Considerations, Methodologies, and Implementations
von: Saurabh Mukhopadhyay, et al.
Veröffentlicht: (2025)

An Ensemble Classifier for Ordinal Outcomes in High‐Dimensional Genomics Data
von: Heranga K. Rathnasekara, et al.
Veröffentlicht: (2026)

A Commensurate Prior Model With Random Effects for Survival and Competing Risk Outcomes to Accommodate Historical Controls
von: Manoj Khanal, et al.
Veröffentlicht: (2025)

Bayesian Solutions for Assessing Differential Effects in Biomarker Positive and Negative Subgroups
von: Dan Jackson, et al.
Veröffentlicht: (2024)

Personalized Treatment Selection for Multivariate Ordinal Scale Outcomes and Multiple Treatments
von: Chathura Siriwardhana, et al.
Veröffentlicht: (2025)

An Association Test for Ordinal Outcomes in Clustered Data With Informative Cluster Size
von: Hasika K. Wickrama Senevirathne, et al.
Veröffentlicht: (2026)